Biocartis NV and Merck Join Forces to Improve Patient Access to Personalized Medicine in the Middle East and North Africa (MEA) Region

Monday, May 06, 2024

Biocartis, based in Mechelen, Belgium, has expanded its collaboration with Merck Serono Middle East and Merck Saudi Ltd., both affiliates of Merck KGaA, to improve RAS biomarker testing access in the Middle East and North Africa (MEA) region.

Colorectal cancer (CRC) ranks as the third most common cancer worldwide, with over 1.9 million new cases annually. Unfortunately, it's also the second leading cause of cancer-related deaths, claiming about 904 thousand lives each year.

Identifying a patient's biomarker status is vital for timely treatment decisions in metastatic colorectal cancer (mCRC).

Treatment with anti-epidermal growth factor receptor (EGFR) monoclonal antibody therapies has shown improved outcomes in patients with RAS wild-type mCRC, becoming the standard of care for this group.

RAS biomarker testing is not universally accessible and can be cumbersome. Biocartis' Idylla™ KRAS Mutation Test and Idylla™ NRAS-BRAF Mutation Test offer highly accurate results and can quickly determine RAS biomarker status in mCRC tumor tissue samples.

Idylla™ Platform allows deployment in various settings, thereby enhancing patient access to biomarker testing worldwide.

Expanding the collaboration with Merck in the MEA region, aiming to advance healthcare solutions and ensure accurate diagnostics for mCRC patients.

The collaboration reflects their mutual commitment to overcoming healthcare challenges in the MEA region and ensuring timely personalized medicine delivery.

The collaboration's focus on addressing the critical need for improved access to RAS biomarker testing, particularly in areas where it's lacking.

Leveraging Biocartis' RAS-testing platform is expected to expedite biomarker status determination and enable prompt treatment decisions for patients with metastatic colorectal cancer.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024